AREV Life Sciences Global Corp. (OTCPK: AREV.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
AREV Life Sciences Global Corp. (OTCPK: AREV.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.88K and employs 2 people.
trading between 0.00 and 0.00.
Tweenvest scores AREV Life Sciences Global Corp. across four factors: quality 8/100, value 39/100. Its strongest factor is value.
AREV.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.88K
- Revenue (TTM)
- $5.33K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 4.94
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 31.76M
- Employees
- 2
- Next earnings
- —
About AREV Life Sciences Global Corp.
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. The company's CBD-infused products, include Canna-Mulsion and NaturVax, anti- viral supplements; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product; and white label cannabis products, as well as a range of THC products, and cannabis skincare products and medicinal oils and edibles. Its ingredients are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. In addition, the company's products address the areas of health, which include sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, as well as other specific ailments. Further, it offers nutraceutical product formulations under the Bare brand name; and ready-to-use therapeutic food products under the SUS-TAINN name. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. was incorporated in 2005 and is based in Coquitlam, Canada.
- ISIN
- CA04019J1093
- Listed since
- Jan 4, 2000
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.